Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Johnson and Johnson
Medtronic
Baxter
Boehringer Ingelheim

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

FISH OIL TRIGLYCERIDES - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for fish oil triglycerides and what is the scope of patent protection?

Fish oil triglycerides is the generic ingredient in one branded drug marketed by Fresenius Kabi Usa and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Fish oil triglycerides has five patent family members in four countries.

There are six drug master file entries for fish oil triglycerides. One supplier is listed for this compound.

Summary for FISH OIL TRIGLYCERIDES
International Patents:5
US Patents:3
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 6
Suppliers / Packagers: 1
Clinical Trials: 579
Formulation / Manufacturing:see details
DailyMed Link:FISH OIL TRIGLYCERIDES at DailyMed
Recent Clinical Trials for FISH OIL TRIGLYCERIDES

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Wisconsin, MadisonPhase 1
Matinas Biopharma, IncPhase 2
MB Clinical Research and Consulting LLCPhase 2

See all FISH OIL TRIGLYCERIDES clinical trials

US Patents and Regulatory Information for FISH OIL TRIGLYCERIDES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa OMEGAVEN fish oil triglycerides EMULSION;INTRAVENOUS 210589-001 Jul 27, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Fresenius Kabi Usa OMEGAVEN fish oil triglycerides EMULSION;INTRAVENOUS 210589-001 Jul 27, 2018 RX Yes Yes   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa OMEGAVEN fish oil triglycerides EMULSION;INTRAVENOUS 210589-001 Jul 27, 2018 RX Yes Yes   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa OMEGAVEN fish oil triglycerides EMULSION;INTRAVENOUS 210589-002 Jul 27, 2018 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Baxter
Boehringer Ingelheim
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.